Pfizer, BioNTech to Offer COVID-19 Vaccine to Volunteers Who Got Placebo

U.S.-based Pfizer and its Germany-based partner BioNTech plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a first dose of the vaccine by March 1, 2021.

“All participants aged 16 years and older who courageously volunteered to help make a difference during this pandemic have the option to receive the investigational vaccine while continuing to be part of the clinical trial,” the companies said on their website.

The U.S. Food and Drug Administration and a panel of its outside advisers have expressed...